Missouri Trust & Investment Company’s Pfizer PFE Stock Holding History

Missouri Trust & Investment Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75M	Buy	70,041 +4,398	+7%	+$115K	0.48%	50
2026 Q1	$1.84M	Buy	65,643 +1,107	+2%	+$29.5K	0.54%	39
2025 Q4	$1.61M	Buy	64,536 +8,550	+15%	+$216K	0.47%	48
2025 Q3	$1.43M	Buy	55,986 +2,425	+5%	+$59.9K	0.42%	49
2025 Q2	$1.3M	Buy	53,561 +234	+0.4%	+$5.46K	0.42%	55
2025 Q1	$1.35M	Buy	53,327 +1,570	+3%	+$41.1K	0.47%	47
2024 Q4	$1.37M	Buy	51,757 +1,801	+4%	+$48.9K	0.48%	42
2024 Q3	$1.45M	Buy	49,956 +3,885	+8%	+$113K	0.5%	42
2024 Q2	$1.29M	Buy	46,071 +9,231	+25%	+$254K	0.49%	43
2024 Q1	$1.02M	Buy	36,840 +13,185	+56%	+$366K	0.39%	57
2023 Q4	$681K	Buy	23,655 +3,888	+20%	+$118K	0.28%	71
2023 Q3	$656K	Buy	19,767 +386	+2%	+$13.7K	0.3%	69
2023 Q2	$711K	Buy	19,381 +324	+2%	+$12.6K	0.4%	59
2023 Q1	$778K	Buy	19,057 +1,695	+10%	+$73.2K	0.5%	51
2022 Q4	$890K	Buy	17,362 +1,315	+8%	+$63K	0.53%	44
2022 Q3	$702K	Buy	16,047 +125	+0.8%	+$6.07K	0.46%	51
2022 Q2	$835K	Buy	15,922 +1,525	+11%	+$77.7K	0.55%	43
2022 Q1	$745K	Buy	14,397 +4,914	+52%	+$255K	0.44%	56
2021 Q4	$560K	Buy	+9,483	New	+$470K	0.32%	66

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Missouri Trust & Investment Company's PFE Position: Q2 2026 in Review

Missouri Trust & Investment Company increased its Pfizer (PFE) stake by 6.7% in Q2 2026, buying an estimated $115K and bringing the position to 70,041 shares worth $1.75M. The position accounts for 0.48% of the portfolio, ranked #50.

Missouri Trust & Investment Company first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.84M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Missouri Trust & Investment Company held 70,041 shares of Pfizer worth $1.75M as of Q2 2026.
Missouri Trust & Investment Company bought 4,398 Pfizer shares in Q2 2026, an estimated $115K.
Pfizer made up 0.48% of Missouri Trust & Investment Company's portfolio in Q2 2026, its #50 holding.
Missouri Trust & Investment Company first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
Missouri Trust & Investment Company's Pfizer position peaked at $1.84M in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.